Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2019-11-14 | 2020-01-17 | 98738 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-11-14 | 2020-12-17 | 98747 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-11-14 | 2021-01-07 | 98750 |
TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2019-11-14 | 2021-01-07 | 98753 |
TEVA-METOPROLOL | 100MG | TABLET | Resolved | 2019-11-14 | 2021-01-07 | 98756 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-21 | 2020-09-03 | 99429 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2019-11-21 | 2020-04-23 | 99435 |
TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2019-11-21 | 2020-02-13 | 99438 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Resolved | 2019-11-21 | 2020-01-24 | 99444 |
TEVA-CHLOROQUINE | 250MG | TABLET | Actual shortage | 2019-11-21 | 2020-07-10 | 99447 |
TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2019-11-21 | 2020-12-17 | 99450 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-11-28 | 2020-05-01 | 99856 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2019-11-28 | 2020-01-24 | 99929 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2019-11-28 | 2020-04-23 | 99932 |
TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Actual shortage | 2019-11-28 | 2021-10-14 | 99938 |
TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99944 |
TEVA-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-11-28 | 2022-01-07 | 99952 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2019-11-28 | 2020-08-21 | 99959 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |